"10.1371_journal.pone.0148043","plos one","2016-01-29T00:00:00Z","Tam√°s Kaucs√°r; M√°ria God√≥; Csaba R√©v√©sz; Mikl√≥s Kov√°cs; Attila M√≥csai; Norbert Kiss; Mih√°ly Albert; Tibor Kren√°cs; G√°bor Sz√©n√°si; P√©ter Hamar","Institute of Pathophysiology, Semmelweis University, Budapest, Hungary; MTA-SE ‚ÄúLend√ºlet‚Äù Inflammation Physiology Research Group, Department of Physiology, Semmelweis University, Budapest, Hungary; CEVA Phylaxia Ltd., Budapest, Hungary; MTA-SE Tumor Progression Research Group, 1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary","Conceived and designed the experiments: T. Kaucs√°r MG PH. Performed the experiments: T. Kaucs√°r MG CR MA NK T. Kren√°cs MK. Analyzed the data: T. Kaucs√°r GS PH. Contributed reagents/materials/analysis tools: PH AM T. Kren√°cs. Wrote the paper: T. Kaucs√°r GS PH. Provided the neutrophil deficient mice: AM. Provided infrastructure for tissue microarray analysis: T. Kren√°cs.","CEVA Phylaxia Ltd. did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mih√°ly Albert evaluated FFPE kidney sections histologically during his spare time at the authors lab as a private person and not as an employee of CEVA Phylaxia Ltd. CEVA Phylaxia Ltd. has no interest in renal disease biomarkers. Furthermore, this commercial affiliation does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2016","01","Tam√°s Kaucs√°r","T√K√",10,TRUE,1,1,1,1,TRUE,TRUE,TRUE,6,"2;3;4;6;7;9",TRUE
